← All tickers

Is NVAX Worth Buying in 2026?

Novavax Inc

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-07-26

Here’s whether Novavax Inc (NVAX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.41% over 10 days); RSI 14 — oversold; 3-month momentum negative (-9.2%). Currently 37.7% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

NVAX is trading below its 200-day MA ($8.50) — a key warning sign the longer-term trend is under pressure. An RSI of 13.9 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -2.4% compares to +16.5% for SPY (trailed the market by 18.8%). The current 37.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $9,764 today
vs. S&P 500 (SPY) — same period trailed market by 18.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($8.50)
✗Above 50-day MA ($9.15)
!RSI(14) neutral zone (30–70) — currently 13.9
✗Positive return (-2.4%)
!Within 10% of period high (−37.7%)
Period Range $7.46
$6.20 $11.97
RSI (14) 13.9
0 · OversoldOverbought · 100

Key Metrics

Price$7.46
Period Return-2.4%
Period High$11.97
Period Low$6.20
Drawdown−37.7%
MA-50$9.15
MA-200$8.50
RSI (14)13.9
Avg Volume (30d)3.9M
vs. SPYtrailed by 18.8%
Return Rank#540 of 999

Trade NVAX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers